Our findings demonstrated that LINC00958 is overexpressed in certain specific cancer types, including BLCA, CESC, COAD, esophageal carcinoma (ESCA), HNSC, kidney chromophobe (KICH), kidney renal papillary cell carcinoma (KIRP), LIHC, lung adenocarcinoma (LUAD), LUSC, THCA, and UCEC (Figure 5C). Here, LINC00958 is linked to bladder transitional cell carcinoma.